Wakefield Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-59,637
Closed -$740K 157
2024
Q1
$740K Buy
59,637
+406
+0.7% +$5.3K 0.26% 120
2023
Q4
$828K Buy
+59,231
New +$823K 0.31% 108
2021
Q2
Sell
-84,101
Closed -$827K 160
2021
Q1
$827K Buy
+84,101
New +$693K 0.33% 88

Other funds holding DVAX

Wakefield Asset Management's DVAX Position: Q2 2024 in Review

Wakefield Asset Management sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 59,637 shares — an estimated $740K sold.

Wakefield Asset Management first reported a position in DVAX in Q1 2021 and held it in 3 quarters. The position peaked at $828K in Q4 2023. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

  • Wakefield Asset Management reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
  • Wakefield Asset Management sold 59,637 Dynavax Technologies shares in Q2 2024, an estimated $740K.
  • Wakefield Asset Management first reported a position in Dynavax Technologies in Q1 2021 and held it in 3 quarters.
  • Wakefield Asset Management's Dynavax Technologies position peaked at $828K in Q4 2023.
  • 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on Wakefield Asset Management's 13F filing for Q2 2024, filed 5 Aug 2024.